INNV
InnovAge Holding Corp
NASDAQ: INNV · HEALTHCARE · MEDICAL CARE FACILITIES
$7.96
-2.57% today
Updated 2026-05-05
Market cap
$1.08B
P/E ratio
159.20
P/S ratio
1.18x
EPS (TTM)
$0.05
Dividend yield
—
52W range
$3 – $11
Volume
0.3M
WallStSmart proprietary scores
31
out of 100
Grade: F
Strong Sell
Investment rating
4.7
Growth
C6.0
Quality
B4.5
Profitability
C5.7
Valuation
C+5/9
Piotroski F-Score
Moderate
1.7
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →197 stocks currently score above 75
Price targets
Analyst target
$7.00
-12.06%
12-Month target
$0.34
-95.73%
Intrinsic (DCF)
$15.02
Margin of safety
+45.54%
0 Strong Buy0 Buy2 Hold0 Sell1 Strong Sell
Price chart
Stock snapshot
Strengths
+ Free cash flow $19.00M — positive
+ Revenue growth 14.70% QoQ
+ 45.54% below intrinsic value
+ Debt/equity 0.46x — low leverage
Risks
- Altman Z 1.74 — distress zone
- Thin margins at 0.71%
- P/E 159.20x — expensive valuation
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $698.64M | $688.09M | $763.86M | $853.70M | $915.37M |
| Net income | $-6.52M | $-40.67M | $-21.34M | $-30.31M | $10.62M |
| EPS | — | — | — | — | $0.05 |
| Free cash flow | $-10.94M | $-44.81M | $-44.81M | $26.60M | $19.00M |
| Profit margin | -0.93% | -5.91% | -2.79% | -3.55% | 0.71% |
Peer comparison
Smart narrative
InnovAge Holding Corp trades at $7.96. representing a P/E of 159.20x trailing earnings. Our Smart Value Score of 31/100 indicates the stock is weak. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 1.74, it sits in the distress. TTM revenue stands at $915.37M. with profit margins at 0.71%. Our DCF model estimates intrinsic value at $15.02.
Frequently asked questions
What is InnovAge Holding Corp's stock price?
InnovAge Holding Corp (INNV) trades at $7.96.
Is InnovAge Holding Corp overvalued?
Smart Value Score 31/100 (Grade F, Strong Sell). DCF value $15.02.
What is the price target of InnovAge Holding Corp (INNV)?
The analyst target price is $7.00, representing -12.1% downside from the current price of $7.96.
What is the intrinsic value of InnovAge Holding Corp (INNV)?
Based on our DCF model, intrinsic value is $15.02, a +45.5% margin of safety versus $7.96.
What is InnovAge Holding Corp's revenue?
TTM revenue is $915.37M.
Piotroski F-Score?
5/9 — moderate financial health.
Altman Z-Score?
1.74 — distress.
Company info
SectorHEALTHCARE
IndustryMEDICAL CARE FACILITIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.18x
ROE1.18%
Beta0.49
50D MA$8.37
200D MA$5.93
Shares out0.14B
Float0.02B
Short ratio—
Avg volume0.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—